Related Experiment Video
Updated: Aug 1, 2025

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
Published on: April 21, 2018
Antimicrobial Activity of Apis mellifera Bee Venom Collected in Northern Peru
Orlando Pérez-Delgado1, Abraham Omar Espinoza-Culupú1, Elmer López-López2
1Health Science Research Laboratory, Universidad Señor de Sipán, Chiclayo 14001, Peru.
Abstract:
Due to the emergence of microorganisms resistant to antibiotics and the failure of antibiotic therapies, there is an urgent need to search for new therapeutic options, as well as new molecules with antimicrobial potential. The objective of the present study was to evaluate the in vitro antibacterial activity of Apis mellifera venom collected in the beekeeping areas of the city of Lambayeque in northern Peru against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. Bee venom extraction was performed by electrical impulses and separated using the Amicon ultra centrifugal filter. Subsequently, the fractions were quantified by spectrometric 280 nm and evaluated under denaturant conditions in SDS-PAGE. The fractions were pitted against Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 29213, and Pseudomonas aeruginosa ATCC 27853. A purified fraction (PF) of the venom of A. mellifera and three low molecular weight bands of 7 KDa, 6 KDa, and 5 KDa were identified that showed activity against E. coli with a MIC of 6.88 µg/mL, while for P. aeruginosa and S. aureus, it did not present a MIC. No hemolytic activity at a concentration lower than 15.6 µg/mL and no antioxidant activity. The venom of A. mellifera contains a potential presence of peptides and a predilection of antibacterial activity against E. coli.
Insights
The study found that Apis mellifera (honey bee) venom has antibacterial properties, particularly against E. coli. This bee venom may offer a new source for antimicrobial compounds to combat antibiotic resistance.
Area of Science:
- Microbiology
- Pharmacology
- Biochemistry
Background:
- Antibiotic resistance necessitates novel therapeutic strategies.
- Exploring natural products for antimicrobial agents is crucial.
- Apis mellifera venom is a potential source of bioactive compounds.
Purpose of the Study:
- To investigate the in vitro antibacterial activity of Apis mellifera venom.
- To identify active fractions against specific bacterial pathogens.
- To assess hemolytic and antioxidant properties of the venom.
Main Methods:
- Bee venom collected and extracted using electrical impulses.
- Venom fractions separated via Amicon ultra centrifugal filter.
- Antibacterial activity evaluated against E. coli, P. aeruginosa, and S. aureus using MIC assays.
Main Results:
- A purified fraction (PF) and low molecular weight bands (7, 6, 5 KDa) showed activity against E. coli (MIC: 6.88 µg/mL).
- No significant activity was observed against P. aeruginosa and S. aureus.
- No hemolytic activity below 15.6 µg/mL and no antioxidant activity detected.
Conclusions:
- Apis mellifera venom contains peptides with potential antibacterial activity.
- The venom exhibits a predilection for antibacterial action against E. coli.
- Further research into bee venom components could yield new antimicrobial drugs.

